BACKGROUND: Infiltrating macrophage count (IMC) is found to correlate with the progression and prognosis of many human cancers. METHODS: This study used immunohistochemistry to measure the IMC (macrophages/high-power field [HPF]) in 92 specimens of oral squamous cell carcinoma (OSCC). RESULTS: A significantly increased IMC was found in OSCCs with larger tumor size, positive lymph node metastasis, more advanced clinical stages, or recurrence (all ps < .05). Kaplan-Meier survival analysis found that OSCC patients with IMC >196 macrophages/HPF had a significantly shorter disease-free (p = .001, log-rank test) or overall survival (p < .001, log-rank test) than OSCC patients with IMC <196 macrophages/HPF. Multivariate Cox regression analyses showed that IMC >196 macrophages/HPF was an independent predictor for poor disease-free (p = .005) and overall survival of patients with OSCC (p = .015). CONCLUSIONS: The IMC can predict the progression and prognosis of OSCCs in Taiwan.
BACKGROUND: Infiltrating macrophage count (IMC) is found to correlate with the progression and prognosis of many humancancers. METHODS: This study used immunohistochemistry to measure the IMC (macrophages/high-power field [HPF]) in 92 specimens of oral squamous cell carcinoma (OSCC). RESULTS: A significantly increased IMC was found in OSCCs with larger tumor size, positive lymph node metastasis, more advanced clinical stages, or recurrence (all ps < .05). Kaplan-Meier survival analysis found that OSCC patients with IMC >196 macrophages/HPF had a significantly shorter disease-free (p = .001, log-rank test) or overall survival (p < .001, log-rank test) than OSCC patients with IMC <196 macrophages/HPF. Multivariate Cox regression analyses showed that IMC >196 macrophages/HPF was an independent predictor for poor disease-free (p = .005) and overall survival of patients with OSCC (p = .015). CONCLUSIONS: The IMC can predict the progression and prognosis of OSCCs in Taiwan.
Authors: Tatiana Smirnova; Alfred Adomako; Joseph Locker; Nico Van Rooijen; Michael B Prystowsky; Jeffrey E Segall Journal: Am J Pathol Date: 2011-06 Impact factor: 4.307
Authors: Falk Wehrhan; Maike Büttner-Herold; Peter Hyckel; Patrick Moebius; Raimund Preidl; Luitpold Distel; Jutta Ries; Kerstin Amann; Christian Schmitt; Friedrich W Neukam; Manuel Weber Journal: BMC Cancer Date: 2014-07-21 Impact factor: 4.430
Authors: Esther Erdei; Li Luo; Huiping Sheng; Erika Maestas; Kirsten A M White; Amanda Mackey; Yan Dong; Marianne Berwick; Douglas E Morse Journal: PLoS One Date: 2013-11-20 Impact factor: 3.240
Authors: Alexander W Eckert; Claudia Wickenhauser; Paul C Salins; Matthias Kappler; Juergen Bukur; Barbara Seliger Journal: J Transl Med Date: 2016-04-05 Impact factor: 5.531